{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:25:16Z","timestamp":1740108316359,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22H04306"],"award-info":[{"award-number":["JP22H04306"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"DOI":"10.1007\/s00228-023-03459-7","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T08:43:44Z","timestamp":1675241024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relationship between elevated bilirubin levels and enhanced warfarin effects during biliary obstruction"],"prefix":"10.1007","author":[{"given":"Takafumi","family":"Nakazawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takako","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itsuko","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,1]]},"reference":[{"key":"3459_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1194\/jlr.R045559","volume":"55","author":"MJ Shearer","year":"2014","unstructured":"Shearer MJ, Newman P (2014) Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis. J Lipid Res 55:345\u2013362. https:\/\/doi.org\/10.1194\/jlr.R045559","journal-title":"J Lipid Res"},{"key":"3459_CR2","doi-asserted-by":"publisher","first-page":"676","DOI":"10.7326\/0003-4819-121-9-199411010-00009","volume":"121","author":"PS Wells","year":"1994","unstructured":"Wells PS, Holbrook AM, Crowther NR, Hirsh J (1994) Interactions of warfarin with drugs and food. Ann Intern Med 121:676\u2013683. https:\/\/doi.org\/10.7326\/0003-4819-121-9-199411010-00009","journal-title":"Ann Intern Med"},{"key":"3459_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/nu12010138","volume":"12","author":"DC Simes","year":"2020","unstructured":"Simes DC, Viegas CSB, Ara\u00fajo N, Marreiros C (2020) Vitamin K as a diet supplement with impact in human health: current evidence in age-related diseases. Nutrients 12:138. https:\/\/doi.org\/10.3390\/nu12010138","journal-title":"Nutrients"},{"key":"3459_CR4","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1001\/archinte.159.22.2647","volume":"159","author":"AF Hofmann","year":"1999","unstructured":"Hofmann AF (1999) The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 159:2647\u20132658. https:\/\/doi.org\/10.1001\/archinte.159.22.2647","journal-title":"Arch Intern Med"},{"key":"3459_CR5","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.3748\/wjg.15.4077","volume":"15","author":"S Savvidou","year":"2009","unstructured":"Savvidou S, Goulis J, Gantzarou A, Ilonidis G (2009) Pneumobilia, chronic diarrhea, vitamin K malabsorption: a pathognomonic triad for cholecystocolonic fistulas. World J Gastroenterol 15:4077\u20134082. https:\/\/doi.org\/10.3748\/wjg.15.4077","journal-title":"World J Gastroenterol"},{"key":"3459_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2710.2004.00583.x","volume":"29","author":"H Konishi","year":"2004","unstructured":"Konishi H, Eguchi Y, Fujii M, Saotome T, Sasaki T, Takahashi K, Sudo M, Morii H, Minouchi T, Yamaji A (2004) Unusual hypersensitivity to warfarin in a critically ill patient. J Clin Pharm Ther 29:485\u2013490. https:\/\/doi.org\/10.1111\/j.1365-2710.2004.00583.x","journal-title":"J Clin Pharm Ther"},{"key":"3459_CR7","unstructured":"Coucke EM, Akbar H, Kahloon A, Lopez PP (2021) Biliary obstruction. StatPearls. Treasure Island (FL): Stat Pearls Publishing; 2021 Jan\u20132021 Sep 28"},{"key":"3459_CR8","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","volume":"165","author":"AM Holbrook","year":"2005","unstructured":"Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, Wells PS (2005) Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 165:1095\u20131106. https:\/\/doi.org\/10.1001\/archinte.165.10.1095","journal-title":"Arch Intern Med"},{"key":"3459_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.molmed.2004.05.003","volume":"10","author":"R Wallin","year":"2004","unstructured":"Wallin R, Hutson SM (2004) Warfarin and the vitamin K-dependent gamma-carboxylation system. Trends Mol Med 10:299\u2013302. https:\/\/doi.org\/10.1016\/j.molmed.2004.05.003","journal-title":"Trends Mol Med"},{"key":"3459_CR10","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.2147\/DDDT.S107917","volume":"10","author":"H Li","year":"2016","unstructured":"Li H, Wang Y, Fan R, Lv H, Sun H, Xie H, Tang T, Luo J, Xia Z (2016) The effects of ferulic acid on the pharmacokinetics of warfarin in rats after biliary drainage. Drug Des Devel Ther 10:2173\u20132180. https:\/\/doi.org\/10.2147\/DDDT.S107917","journal-title":"Drug Des Devel Ther"},{"key":"3459_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/jcpt.13137","volume":"45","author":"T Nakazawa","year":"2020","unstructured":"Nakazawa T, Yamazaki S, Uchida M, Suzuki T, Nakamura T, Takayashiki T, Ohtsuka M, Ishii I (2020) Association of marked prolongation of prothrombin time-international normalized ratio with warfarin and endoscopic nasobiliary drainage for biliary fistula after left hemihepatectomy J Clin Pharm Ther 45:815\u2013818. https:\/\/doi.org\/10.1111\/jcpt.13137","journal-title":"Association of marked prolongation of prothrombin time-international normalized ratio with warfarin and endoscopic nasobiliary drainage for biliary fistula after left hemihepatectomy J Clin Pharm Ther"},{"key":"3459_CR12","unstructured":"Francis P, Navarro VJ (2021) Drug induced hepatotoxicity. StatPearls. Treasure Island (FL): Stat Pearls Publishing\u00a0Jan\u20132021 Mar 23"},{"key":"3459_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2165\/00003088-198916040-00003","volume":"16","author":"HG Shetty","year":"1989","unstructured":"Shetty HG, Fennerty AG, Routledge PA (1989) Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy. Clin Pharmacokinet 16:238\u2013253. https:\/\/doi.org\/10.2165\/00003088-198916040-00003","journal-title":"Clin Pharmacokinet"},{"key":"3459_CR14","doi-asserted-by":"publisher","unstructured":"De Gasperi A, Corti A, Mazza E, Prosperi M, Amici O, Bettinelli L (2009) Acute liver failure: managing coagulopathy and the bleeding diathesis. Transplant Proc 41:1256\u20131259. https:\/\/doi.org\/10.1016\/j.transproceed.2009.03.007","DOI":"10.1016\/j.transproceed.2009.03.007"},{"key":"3459_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jss.2018.02.048","volume":"228","author":"AM Beliaev","year":"2018","unstructured":"Beliaev AM, Booth M, Rowbotham D, Bergin C (2018) Diagnostic inflammatory markers in acute cholangitis. J Surg Res 228:35\u201341. https:\/\/doi.org\/10.1016\/j.jss.2018.02.048","journal-title":"J Surg Res"},{"key":"3459_CR16","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2165\/00003088-199630040-00003","volume":"30","author":"G Palareti","year":"1996","unstructured":"Palareti G, Legnani C (1996) Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations. Clin Pharmacokinet 30:300\u2013313. https:\/\/doi.org\/10.2165\/00003088-199630040-00003","journal-title":"Clin Pharmacokinet"},{"key":"3459_CR17","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/clpt.1981.242","volume":"30","author":"RJ Piroli","year":"1981","unstructured":"Piroli RJ, Passananti GT, Shively CA, Vesell ES (1981) Antipyrine and warfarin disposition in a patient with idiopathic hypoalbuminemia. Clin Pharmacol Ther 30:810\u2013816. https:\/\/doi.org\/10.1038\/clpt.1981.242","journal-title":"Clin Pharmacol Ther"},{"key":"3459_CR18","first-page":"75","volume":"25","author":"D Ganeval","year":"1986","unstructured":"Ganeval D, Fischer AM, Barre J, Pertuiset N, Dautzenberg MD, Jungers P, Houin G (1986) Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors. Clin Nephrol 25:75\u201380","journal-title":"Clin Nephrol"},{"key":"3459_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.2042-7158.1985.tb04974.x","volume":"37","author":"CJ Bowmer","year":"1985","unstructured":"Bowmer CJ, Donoghue PG, Leong CF, Yates MS (1985) Effect of bile acids on the binding of drugs and dyes to human albumin. J Pharm Pharmacol 37:812\u2013815. https:\/\/doi.org\/10.1111\/j.2042-7158.1985.tb04974.x","journal-title":"J Pharm Pharmacol"},{"key":"3459_CR20","doi-asserted-by":"publisher","first-page":"14007","DOI":"10.3390\/ijms232214007","volume":"23","author":"B Lemli","year":"2022","unstructured":"Lemli B, Lomozov\u00e1 Z, Huber T, Luk\u00e1cs A, Po\u00f3r M (2022) Effects of Heme site (FA1) ligands bilirubin, biliverdin, hemin, and methyl orange on the albumin binding of site I marker warfarin: complex allosteric interactions. Int J Mol Sci 23:14007. https:\/\/doi.org\/10.3390\/ijms232214007","journal-title":"Int J Mol Sci"},{"key":"3459_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3143\/geriatrics.56.204","volume":"56","author":"Y Furumi","year":"2019","unstructured":"Furumi Y, Shimizu S, Ogawa Y, Hirose D, Takada Y, Kanetaka H, Sakurai H, Mae A, Hanyu H (2019) A suspicious case of coagulation disorder caused by vitamin K deficiency associated with fasting and antibiotics. Nihon Ronen Igakkai Zasshi 56:204\u2013208. https:\/\/doi.org\/10.3143\/geriatrics.56.204","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"3459_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.psym.2011.01.026","volume":"52","author":"H Nomoto","year":"2011","unstructured":"Nomoto H, Hatta K, Usui C, Ito M, Kita Y, Arai H (2011) Vitamin K deficiency due to prolongation of antibiotic treatment and decrease in food intake in a catatonia patient. Psychosomatics 52:486\u2013487. https:\/\/doi.org\/10.1016\/j.psym.2011.01.026","journal-title":"Psychosomatics"},{"key":"3459_CR23","doi-asserted-by":"publisher","unstructured":"Singer DE, Albers GW, Dalen JE, Fang MC, Go AS, Halperin JL, Lip GYH, Manning WJ (2008) Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:546S\u2013592S. https:\/\/doi.org\/10.1378\/chest.08-0678","DOI":"10.1378\/chest.08-0678"},{"key":"3459_CR24","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2169\/internalmedicine.40.1183","volume":"40","author":"M Yasaka","year":"2001","unstructured":"Yasaka M, Minematsu K, Yamaguchi T (2001) Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 40:1183\u20131188. https:\/\/doi.org\/10.2169\/internalmedicine.40.1183","journal-title":"Intern Med"},{"key":"3459_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jacc.2007.01.098","volume":"50","author":"AY Shen","year":"2007","unstructured":"Shen AY, Yao JF, Brar SS, Jorgensen MB, Chen W (2007) Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol 50:309\u2013315. https:\/\/doi.org\/10.1016\/j.jacc.2007.01.098","journal-title":"J Am Coll Cardiol"},{"key":"3459_CR26","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1365-2125.2005.02361.x","volume":"59","author":"JH You","year":"2005","unstructured":"You JH, Chan FW, Wong RS, Cheng G (2005) Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation? Br J Clin Pharmacol 59:582\u2013587. https:\/\/doi.org\/10.1111\/j.1365-2125.2005.02361.x","journal-title":"Br J Clin Pharmacol"},{"key":"3459_CR27","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/cts.12781","volume":"13","author":"S Agrawal","year":"2020","unstructured":"Agrawal S, Heiss MS, Fenter RB, Abramova TV, Perera MA, Pacheco JA, Smith ME, Rasmussen-Torvik LJ, George AL Jr (2020) Impact of CYP2C9-interacting drugs on warfarin pharmacogenomics. Clin Transl Sci 13:941\u2013949. https:\/\/doi.org\/10.1111\/cts.12781","journal-title":"Clin Transl Sci"},{"key":"3459_CR28","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/0002-9149(83)90673-2","volume":"51","author":"JH Chesebro","year":"1983","unstructured":"Chesebro JH, Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, Wallace RB, Danielson GK, Orszulak TA, Piehler JM, Schaff HV (1983) Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol 51:1537\u20131541. https:\/\/doi.org\/10.1016\/0002-9149(83)90673-2","journal-title":"Am J Cardiol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03459-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-023-03459-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-023-03459-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T08:45:18Z","timestamp":1675241118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-023-03459-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,1]]},"references-count":28,"alternative-id":["3459"],"URL":"https:\/\/doi.org\/10.1007\/s00228-023-03459-7","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2023,2,1]]},"assertion":[{"value":"26 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethical Committee of Chiba University School of Medicine (approval number M10036) and conducted in compliance with the Ethical Guidelines for Medical Research Involving Human Subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}